Thyroid hormones have well-documented effects on the skeleton although the
mechanism of their action on bone is poorly understood. We have recently re
ported the presence of different thyroid hormone receptor isoforms in human
bone. However, there is evidence to suggest that the expression of thyroid
hormone receptor (TR) protein may not necessarily correlate with its mRNA.
In this study, we used specific digoxigenin-labeled ribo probes to investi
gate the expression of TR alpha 1, variant TR alpha 2, TR beta 1, and in pa
rticular TR beta 2 mRNA in human osteophytic bone and osteoclastoma tissue
in situ. The number of positive cells was expressed as the percentage of th
e total number of cells of the same phenotype. In osteophytes, at sites of
endochondral ossification, TR alpha 1, variant TR alpha 2, TR beta 1, and T
R beta 2 mRNA were widely distributed in undifferentiated, proliferating, m
ature and hypertrophic chondrocytes. At sites of bone remodeling, TR alpha
1 mRNA was expressed in the majority (> 90%) of osteoblasts. TR beta 1 and
the variant TR-alpha 2 mRNA were moderately expressed in approximately 75%
of cells with only a few osteoblasts (< 25%) expressing TR beta 2 mRNA. All
the TR transcripts were highly expressed in multinucleated osteoclasts in
osteoclastoma tissue. The distribution of TR mRNAs was similar to TR recept
or protein expression (as we have previously reported) in both osteophytic
bone and osteoclastoma tissue except TR alpha 1 mRNA that was highly expres
sed in osteoclasts and in undifferentiated, proliferating, mature, and hype
rtrophic chondrocytes in contrast to its receptor protein expression. This
study highlights the importance of studying both TR mRNA and receptor prote
ins in triiodothyronine (T-3) responsive tissues. This is also the first de
monstration of the presence of TR beta 2 mRNA in bone. The role of TR beta
2 in mediating the actions of thyroid hormones in bone is not known and req
uires further investigation.